AMY BASHAW: Open Payments
NPI 1386396695 · ELIZABETHTOWN, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$506 in 34 payments from 11 companies in 2025. Trend: 2023 $865 · 2024 $709 · 2025 $506
Food & beverage: $506
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 18 | $236 |
| PFIZER INC. | 4 | $68 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Novo Nordisk Inc | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences Corporation | 1 | $21 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Axsome Therapeutics, Inc. | 1 | $15 |
Products named: VRAYLAR, UBRELVY, NURTEC ODT, CAPLYTA, Rybelsus, Kerendia, Cologuard Collection Kit, TRELEGY ELLIPTA.
Industry payments across KY — which companies pay providers there.
